USSIA, GIAN PAOLO
 Distribuzione geografica
Continente #
AS - Asia 16.277
NA - Nord America 10.248
EU - Europa 3.646
SA - Sud America 1.754
AF - Africa 161
Continente sconosciuto - Info sul continente non disponibili 125
OC - Oceania 90
Totale 32.301
Nazione #
SG - Singapore 10.057
US - Stati Uniti d'America 9.877
CN - Cina 2.395
HK - Hong Kong 2.067
IT - Italia 1.697
BR - Brasile 1.300
VN - Vietnam 714
GB - Regno Unito 548
FR - Francia 448
BD - Bangladesh 332
DE - Germania 296
IN - India 179
AR - Argentina 176
CA - Canada 171
NL - Olanda 131
ID - Indonesia 121
MX - Messico 94
AU - Australia 84
EE - Estonia 82
EC - Ecuador 81
CO - Colombia 60
CZ - Repubblica Ceca 57
ZA - Sudafrica 57
TR - Turchia 53
JP - Giappone 50
IQ - Iraq 49
FI - Finlandia 47
PK - Pakistan 46
ES - Italia 43
RU - Federazione Russa 43
UA - Ucraina 40
CL - Cile 39
PH - Filippine 29
VE - Venezuela 29
MD - Moldavia 26
PL - Polonia 26
PY - Paraguay 26
MA - Marocco 25
JM - Giamaica 22
MY - Malesia 22
AT - Austria 18
TN - Tunisia 18
SA - Arabia Saudita 17
LT - Lituania 16
PE - Perù 16
SE - Svezia 16
CR - Costa Rica 15
IR - Iran 15
UZ - Uzbekistan 14
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
BE - Belgio 12
BO - Bolivia 12
AL - Albania 11
BG - Bulgaria 11
TH - Thailandia 11
CH - Svizzera 10
EG - Egitto 10
GT - Guatemala 10
IL - Israele 10
RO - Romania 10
TT - Trinidad e Tobago 10
DO - Repubblica Dominicana 9
HN - Honduras 9
KE - Kenya 9
AZ - Azerbaigian 8
DZ - Algeria 8
HU - Ungheria 8
JO - Giordania 7
KW - Kuwait 7
KZ - Kazakistan 7
ET - Etiopia 6
IE - Irlanda 6
NI - Nicaragua 6
SV - El Salvador 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
LK - Sri Lanka 5
NP - Nepal 5
NZ - Nuova Zelanda 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BY - Bielorussia 4
GR - Grecia 4
KR - Corea 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
SI - Slovenia 4
BB - Barbados 3
BH - Bahrain 3
CU - Cuba 3
LB - Libano 3
LU - Lussemburgo 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZM - Zambia 3
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
Totale 32.115
Città #
San Jose 2.439
Ashburn 2.233
Hong Kong 2.046
Singapore 1.534
Rome 1.141
Hefei 884
Council Bluffs 585
Boardman 531
Dallas 528
Columbus 468
Lauterbourg 395
Beijing 394
London 394
Shanghai 305
Ho Chi Minh City 264
Phoenix 219
Santa Clara 171
Los Angeles 152
New York 141
Hanoi 136
São Paulo 106
Amsterdam 91
San Francisco 86
Munich 70
West Jordan 61
Toronto 54
Frankfurt am Main 53
Seattle 53
Milan 52
Pune 50
Tallinn 49
Rio de Janeiro 48
Haiphong 46
Tokyo 44
Chicago 43
Curitiba 42
Atlanta 41
Mexico City 41
Washington 41
Brno 40
Brooklyn 37
Montreal 36
Guayaquil 35
Las Vegas 34
Buffalo 33
Brasília 31
Belo Horizonte 25
Turku 25
Da Nang 23
Hangzhou 22
Melbourne 22
Orem 22
Perth 22
Boston 21
Helsinki 21
Nuremberg 20
Porto Alegre 20
Quito 20
Santiago 20
Johannesburg 19
Manchester 19
Naples 19
Biên Hòa 18
Jakarta 18
The Dalles 17
Warsaw 17
Xi'an 17
Bologna 16
Chennai 16
Denver 16
Sydney 16
Baghdad 15
Bogotá 15
Charlotte 15
Medellín 15
Buenos Aires 14
Olomouc 14
Palermo 14
Salvador 14
Shenzhen 14
Thái Bình 14
Canberra 13
Kingston 13
Staten Island 13
Stockholm 13
Surat 13
Bengaluru 12
Goiânia 12
Hanover 12
Jinan 12
Karachi 12
Lahore 12
Miami 12
Ninh Bình 12
San José 12
Tashkent 12
Can Tho 11
Dhaka 11
Manaus 11
Montevideo 11
Totale 17.141
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 459
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 283
[Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?] 273
Current management and prognosis of patients with recurrent myocardial infarction 264
Valve-in-valve technique fixes leaks after TAVI 262
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 256
A NOVEL APPROACH TO DEFINE RISK OF STENT THROMBOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS: THE DERIVATION SCORE 254
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 252
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 251
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013]. 250
HEART VALVE STUDY GROUP CATHQUEST 2011 250
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 249
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 248
Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks 246
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 245
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 241
A case series of treatment of coronary trifurcation with a new technique: " the modified double crush technique" 239
HEART VALVE STUDY GROUP CATHQUEST 12 APRIL 2013 https://www.cathquest.com 235
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 233
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 232
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 232
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 231
LIVE CASE TRANSCATHETER MITRAL VALVE TREATMENT FROM FERRAROTTO HOSPITAL CATANIA ITALY TO VALVE SUMMIT SANTA TECLA (CT) 30 APRIL 2010 228
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 225
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 224
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 223
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 222
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A Contemporary Reappraisal 218
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 218
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 216
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 212
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 206
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 197
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 187
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 175
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 167
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 158
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 156
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 154
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 154
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 151
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 151
2-YEAR RESULTS OF COREVALVE IMPLANTATION THROUGH THE SUBCLAVIAN ACCESS: A PROPENSITY-MATCHED COMPARISON WITH THE FEMORAL ACCESS 151
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION 146
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 141
expert roundtable » Present and Future Challenges in Transcatheter Aortic Valve Replacement 140
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 139
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 134
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 130
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 130
TAVR LIVE CASE WITH COREVALVE AT 16TH ANNUAL SYMPOSIUM OF LIVE SYMPOSIUM OF COMPLEX CORONARY, VALVULAR AND VASCULAR CASES, NEW YORK, NEW YORK, USA 14TH JUNE 2013 129
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 129
"Finding the biomarker" for transcatheter mitral valve repair. Eur J Heart Fail. 2019 126
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 122
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 120
Invasive Assessment of Coronary Microvascular Function 119
ACQUIRED PULMONARY VEIN OBSTRUCTION AFTER OPEN HEART SURGERY 119
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 118
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 115
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 114
ALTRE INDICAZIONI 114
QUALITY-OF-LIFE IN ELDERLY PATIENTS ONE YEAR AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC STENOSIS 112
Analisi dei tests farmacologici acuti nei pazienti con ipertensione arteriosa polmonare precapillare 110
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 109
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 109
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS CANDIDATED TO TRANSCATHETER AORTIC VALVE IMPLANTATION 108
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 106
MANAGEMENT OF IMPLANT FAILURE DURING TRANSCATHETER AORTIC VALVE IMPLANTATION 104
The current paradigm of cardiac troponin increase among athletes 103
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 100
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 93
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 91
Eosinophilic Myocarditis: From Bench to Bedside 89
Edge-to-edge repair for tricuspid regurgitation: 1-year follow-up and clinical implications from the TR-Interventional Study 88
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. 87
Immediate and 12-Month Outcomes of Ischemic Versus Nonischemic Functional Mitral Regurgitation in Patients Treated With MitraClip (from the 2011 to 2012 Pilot Sentinel Registry of Percutaneous Edge-To-Edge Mitral Valve Repair of the European Society of Cardiology) 86
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 85
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 85
The safety of transesophageal echocardiography to guide transcatheter tricuspid valve edge-to-edge repair 84
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 84
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 82
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis 81
EARLY AND MID-TERM OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH LOGISTIC EUROSCORE LESS THAN 20%: A COMPARATIVE ANALYSIS BETWEEN DIFFERENT RISK STRATA 80
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 78
FEASIBILITY OF PERCUTANEOUS TRANSCATETHER MITRAL VALVE REPAIR WITH MITRACLIP SYSTEM USING CONSCIOUS SEDATION 77
Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. 77
Anatomical and Procedural Features Associated with Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement. 77
SAFETY AND EFFECTIVENESS OF THE CATANIA POLYZENE-F COATED STENT IN REAL WORLD CLINICAL PRACTICE: 12-MONTH RESULTS FROM THE ATLANTA 2 REGISTRY 75
UPDATE ON PERCUTANEOUS MITRAL VALVE THERAPY; CLINICAL RESULTS AND REAL LIFE EXPERIENCE 75
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 74
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 70
Leiomatosi intravenosa con interessamento cardiaco: diagnosi e follow-up ecocardiografico 70
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 69
Hemodynamic and Myocardial Metabolic Effects of Inodilator Drugs in Severe Heart Failure 68
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 67
EVALUATION OF THE MORPHOLOGY OF THE OVAL FOSSA FOR PLACEMENT OF DEVICES 67
Cardiovascular medicine heart failure (CVM-HF) index as prognostic model for candidates to MitraClip therapy. 67
Ipertensione arteriosa polmonare "Primitiva" in soggetti con infezione da HIV: descrizione di tre casi 67
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 66
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 66
Totale 15.249
Categoria #
all - tutte 215.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022495 0 0 0 8 3 9 7 10 6 22 11 419
2022/2023206 7 9 21 17 20 8 9 13 2 0 97 3
2023/20241.763 43 149 62 146 134 590 54 303 56 106 41 79
2024/202512.396 261 150 517 174 108 376 195 62 1.148 1.077 4.067 4.261
2025/202614.141 1.202 474 1.267 2.070 467 866 3.313 1.166 1.061 1.142 725 388
2026/20273.286 259 1.310 1.085 632 0 0 0 0 0 0 0 0
Totale 32.301